Targeting Protein-Protein Interaction by Small Molecules
The DOI matches its Crossref record; 119 of the 119 references it cites were found in a registry or an index.
Abstract
Protein-protein interactions (PPIs) are critical regulatory events in physiology and pathology, and they represent an important target space for pharmacological intervention. However, targeting PPIs with small molecules is challenging owing to the large surface area involved in protein-protein binding and the lack of obvious small-molecule-binding pockets at many protein-protein interfaces. Nonetheless, successful examples of small-molecule modulators of PPIs have been growing in recent years. This article reviews some of the recent advances in the discovery of small-molecule regulators of PPIs that involve key oncogenic proteins. Our discussion focuses on the three key modes of action for these small-molecule modulators: orthosteric inhibition, allosteric regulation, and interfacial binding/stabilization. Understanding the opportunities and challenges of these diverse mechanisms will help guide future efforts in developing small-molecule modulators against PPIs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Unless the interaction hotspot can be identified, a small molecule with a reduced footprint has difficulty achieving tight binding owing to insufficient interactions.”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [36]
In the citing paper
“First, the contact interfaces of PPIs typically contain an array of polar and non-polar interactions spread over a large area (1500–3000 Å2) [36].”
From The design and development of covalent protein-protein interaction inhibitors for cancer treatment (2020) · cites this paper as [36]
Citations
Cites
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The metabolism of tumors in the body
Warburg, O., Wind, F., & Negelein, E. (1927) · Journal of General Physiology · doi:10.1085/jgp.8.6.519 · Cited by 4,416
Selective inhibition of BET bromodomains
Filippakopoulos, P., Qi, J., Picaud, S., Shen, Y., Smith, W. B., Fedorov, O., Morse, E. M., Keates, T., Hickman, T. T., Felletar, I., et al. (2010) · Nature · doi:10.1038/nature09504 · Cited by 4,262
The landscape of somatic copy-number alteration across human cancers
Beroukhim, R., Mermel, C. H., Porter, D., Wei, G., Raychaudhuri, S., Donovan, J., Barretina, J., Boehm, J. S., Dobson, J., Urashima, M., et al. (2010) · Nature · doi:10.1038/nature08822 · Cited by 4,017
Otto Warburg's contributions to current concepts of cancer metabolism
Koppenol, W. H., Bounds, P. L., & Dang, C. V. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3038 · Cited by 3,427
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
Oltersdorf, T., Elmore, S. W., Shoemaker, A. R., Armstrong, R. C., Augeri, D. J., Belli, B. A., Bruncko, M., Deckwerth, T. L., Dinges, J., Hajduk, P. J., et al. (2005) · Nature · doi:10.1038/nature03579 · Cited by 3,416
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
BET Bromodomain Inhibition as a Therapeutic Strategy to Target c-Myc
Delmore, J. E., Issa, G. C., Lemieux, M. E., Rahl, P. B., Shi, J., Jacobs, H. M., Kastritis, E., Gilpatrick, T., Paranal, R. M., Qi, J., et al. (2011) · Cell · doi:10.1016/j.cell.2011.08.017 · Cited by 2,813
Research works printed but not linked: 5
- Donovan S, 2002, Biochim. Biophys. Acta, 1602, 23
- French CA, 2003, Cancer Res., 63, 304
- Weber CK, 2001, Cancer Res., 61, 3595
- van Veelen CW, 1979, Cancer Res., 39, 4263
- van Veelen CW, 1978, Cancer Res., 38, 4681
Cited by
Induced protein degradation: an emerging drug discovery paradigm
Lai, A. C., & Crews, C. M. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2016.211 · Cited by 1,486
Electrostatic Interactions in Protein Structure, Folding, Binding, and Condensation
Zhou, H.-X., & Pang, X. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00305 · Cited by 1,190
Principles for targeting RNA with drug-like small molecules
Warner, K. D., Hajdin, C. E., & Weeks, K. M. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.93 · Cited by 749
Chemistries of bifunctional PROTAC degraders
Cao, C., He, M., Wang, L., He, Y., & Rao, Y. (2022) · Chemical Society Reviews · doi:10.1039/d2cs00220e · Cited by 313
Mapping the energetic and allosteric landscapes of protein binding domains
Faure, A. J., Domingo, J., Schmiedel, J. M., Hidalgo-Carcedo, C., Diss, G., & Lehner, B. (2022) · Nature · doi:10.1038/s41586-022-04586-4 · Cited by 246
Metadata
- Authors
- Jin, L., Wang, W., & Fang, G.
- Affiliations
- Discovery Oncology and
- Genentech (US)
- AbbVie (United States) (US)
- ORCID
- Wang, Weiru
- Venue
- Annual Review of Pharmacology and Toxicology
- Publisher
- Annual Reviews
- Published
- 2014-01-06
- Volume
- 54
- Issue
- 1
- Pages
- 435-456
- ISSN
- 0362-1642 (ISSN-L)
- 1545-4304
- OpenAlex
- W2153411138
- Cited by
- 195
- References
- 119
- Citations by year
- 2026: 7 · 2025: 6 · 2024: 13 · 2023: 17 · 2022: 13 · 2021: 20 · 2020: 20 · 2019: 17 · 2018: 17 · 2017: 11 · 2016: 24 · 2015: 22 · 2014: 7
- FWCI
- 1.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Annual Review of Pharmacology and Toxicology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Physical Sciences › Chemistry › Organic Chemistry › Chemical Synthesis and Analysis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Degradation and Inhibitors
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Keywords
- protein-protein interaction, small molecule modulators, PPI inhibitors, oncoprotein, allosteric regulation, interfacial binding, protein-protein interfaces, drug discovery
- MeSH terms
- Thyroid Hormone-Binding Proteins, Carrier Proteins, Humans, Membrane Proteins, Models, Molecular, Protein Binding, Thyroid Hormones, ras Proteins, SOS1 Protein, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins c-akt, Protein Interaction Domains and Motifs, Molecular Targeted Therapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Targeting Protein-Protein Interaction by Small Molecules. https://app.cochat.ai/papers/10.1146/annurev-pharmtox-011613-140028
- The paper
- Jin, L., Wang, W., & Fang, G. (2014). Targeting Protein-Protein Interaction by Small Molecules. Annual Review of Pharmacology and Toxicology. https://doi.org/10.1146/annurev-pharmtox-011613-140028
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.